• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结节病器官受累的三级筛查

The three tiers of screening for sarcoidosis organ involvement.

作者信息

Judson Marc A

机构信息

Division of Pulmonary and Critical Care Medicine, Albany Medical College, MC-91, 47 New Scotland Avenue, Albany, NY 12208, USA.

出版信息

Respir Med. 2016 Apr;113:42-9. doi: 10.1016/j.rmed.2016.02.011. Epub 2016 Feb 23.

DOI:10.1016/j.rmed.2016.02.011
PMID:27021579
Abstract

Sarcoidosis may involve any organ in the body. Organ involvement with sarcoidosis may go undetected. This manuscript addresses a suggested approach to screening for sarcoidosis organ involvement. As sarcoidosis organ involvement may never cause symptoms or clinical problems, it is not always necessary to expend the time or expense to detect all organs involved with sarcoidosis. On the other hand, some forms of sarcoidosis organ involvement may have potentially severe consequences such as permanent vision impairment from eye sarcoidosis and sudden death from cardiac sarcoidosis. We believe it useful to describe three tiers of screening for sarcoidosis organ involvement. The first tier of screening involves eliciting a medical history and performing a physical examination. This is a useful screen for all organs. The second tier of screening involves performing specific laboratory tests to search for specific sarcoidosis organ involvement, even if there is no clinical sign or symptom to suggest involvement of that organ. Such screening is only recommended for a limited number of specific organs. The third tier of screening is complex and involves the performance of multiple tests/algorithms or examinations by subspecialists to search for specific organ involvement. The third tier of screening is used to evaluate eye sarcoidosis, vitamin D dysregulation associated with sarcoidosis, and cardiac sarcoidosis. It is hoped that this approach to screening for sarcoidosis organ involvement will be a springboard for rigorous examination of this process that is likely to benefit sarcoidosis patients.

摘要

结节病可能累及身体的任何器官。结节病累及器官的情况可能未被发现。本手稿阐述了一种针对结节病器官受累情况的筛查建议方法。由于结节病累及器官可能从不引起症状或临床问题,所以并不总是需要花费时间和费用去检测所有受累器官。另一方面,某些形式的结节病器官受累可能会产生潜在的严重后果,比如眼部结节病导致的永久性视力损害以及心脏结节病导致的猝死。我们认为描述结节病器官受累的三层筛查方法是有用的。第一层筛查包括询问病史和进行体格检查。这对所有器官来说都是一种有用的筛查。第二层筛查包括进行特定的实验室检查以寻找特定的结节病器官受累情况,即使没有临床迹象或症状提示该器官受累。这种筛查仅推荐用于有限数量的特定器官。第三层筛查较为复杂,涉及由专科医生进行多项检查/算法或检查以寻找特定器官受累情况。第三层筛查用于评估眼部结节病、与结节病相关的维生素D调节异常以及心脏结节病。希望这种结节病器官受累情况的筛查方法将成为严格审视这一过程的跳板,这可能会使结节病患者受益。

相似文献

1
The three tiers of screening for sarcoidosis organ involvement.结节病器官受累的三级筛查
Respir Med. 2016 Apr;113:42-9. doi: 10.1016/j.rmed.2016.02.011. Epub 2016 Feb 23.
2
Screening Sarcoidosis Patients for Occult Disease.筛查结节病患者的隐匿性疾病。
Semin Respir Crit Care Med. 2020 Oct;41(5):741-757. doi: 10.1055/s-0040-1709496. Epub 2020 Aug 10.
3
[Multisystemic sarcoidosis. A clinical case report].[多系统结节病。一例临床病例报告]
Recenti Prog Med. 1990 Dec;81(12):801-3.
4
[Histologic diagnosis of sarcoidosis].[结节病的组织学诊断]
Nihon Rinsho. 2002 Sep;60(9):1759-65.
5
A proposed solution to the clinical assessment of sarcoidosis: the sarcoidosis three-dimensional assessment instrument (STAI).结节病临床评估的一种提议解决方案:结节病三维评估工具(STAI)。
Med Hypotheses. 2007;68(5):1080-7. doi: 10.1016/j.mehy.2006.09.041. Epub 2006 Nov 14.
6
Update of ocular manifestations in sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis. 2002 Oct;19(3):167-75.
7
[Diagnostic Guideline and Criteria for Sarcoidosis--2006].[结节病诊断指南与标准——2006年]
Nippon Ganka Gakkai Zasshi. 2007 Feb;111(2):117-21.
8
Sarcoidosis: a comprehensive review and update for the dermatologist: part II. Extracutaneous disease.结节病:皮肤科医生的全面综述和更新:第二部分。皮肤外疾病。
J Am Acad Dermatol. 2012 May;66(5):719.e1-10; quiz 729-30. doi: 10.1016/j.jaad.2012.02.003.
9
The Clinical Features of Sarcoidosis: A Comprehensive Review.结节病的临床特征:全面综述。
Clin Rev Allergy Immunol. 2015 Aug;49(1):63-78. doi: 10.1007/s12016-014-8450-y.
10
[Diagnosis of cardiac sarcoidosis and follow-up of 24 consecutive patients].[心脏结节病的诊断及24例连续患者的随访]
Rev Med Interne. 2004 May;25(5):357-62. doi: 10.1016/j.revmed.2003.12.018.

引用本文的文献

1
Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis.心肌结节病:表型、诊断、治疗和预后。
Eur Heart J. 2023 May 1;44(17):1495-1510. doi: 10.1093/eurheartj/ehad067.
2
Clinical characteristics and outcomes of Korean patients with sarcoidosis.韩国结节病患者的临床特征和结局。
Sci Rep. 2021 Dec 8;11(1):23700. doi: 10.1038/s41598-021-03175-1.
3
A Comprehensive Review of Sarcoidosis Diagnosis and Monitoring for the Pulmonologist.肺科医生结节病诊断与监测的全面综述
Pulm Ther. 2021 Dec;7(2):309-324. doi: 10.1007/s41030-021-00161-w. Epub 2021 Jun 6.
4
Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts.结节病的临床特征和器官系统受累:明尼苏达大学队列与其他队列的比较。
BMC Pulm Med. 2020 Jun 1;20(1):155. doi: 10.1186/s12890-020-01191-x.
5
Presence of onconeural antibodies in sarcoidosis patients with parasarcoidosis syndrome.患有副结节病综合征的结节病患者体内存在肿瘤神经抗体。
Sarcoidosis Vasc Diffuse Lung Dis. 2019;36(4):254-260. doi: 10.36141/svdld.v36i4.8745. Epub 2019 May 1.
6
Risk of gastrointestinal events among patients with sarcoidosis: a population-based study 1976-2013.结节病患者胃肠道事件的风险:一项基于人群的1976 - 2013年研究
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(3):239-244. doi: 10.36141/svdld.v35i3.6561. Epub 2018 Apr 28.
7
A case report of steroid resistant cardiac sarcoidosis successfully managed with methotrexate.一例使用甲氨蝶呤成功治疗的类固醇难治性心脏结节病病例报告。
Sarcoidosis Vasc Diffuse Lung Dis. 2018;35(2):178-181. doi: 10.36141/svdld.v35i2.6554. Epub 2018 Apr 28.
8
Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns.开发针对结节病的更优药物:根据患者和临床医生的关注点确定治疗适应症及评估治疗效果的终点指标。
F1000Res. 2019 Dec 30;8. doi: 10.12688/f1000research.20696.1. eCollection 2019.
9
Cardiac Involvement in Sarcoidosis Deaths in Wayne County, Michigan: A 20-Year Retrospective Study.密歇根州韦恩县结节病死亡病例中的心脏受累情况:一项20年回顾性研究
Acad Forensic Pathol. 2018 Sep;8(3):718-728. doi: 10.1177/1925362118797744. Epub 2018 Aug 31.
10
Bone marrow involvement in sarcoidosis: an elusive extrapulmonary manifestation.结节病的骨髓受累:一种难以捉摸的肺外表现。
J Community Hosp Intern Med Perspect. 2019 Apr 12;9(2):150-154. doi: 10.1080/20009666.2019.1575688. eCollection 2019 Apr.